Beauty Store Business magazine - January, 2020

FDA

Statement Released From ICMAD Supports Updated Beauty Industry Law

Pam Busiek, president and CEO of Independent Cosmetic Manufacturers and Distributors (ICMAD), vocalized her support for the Modernization of Cosmetics Regulation Act of 2018 in a statement released on February 25th. ICMAD, a non-profit trade association that has supported the beauty business from startups to established multinational corporations since 1974, continues to advocate for businesses of all sizes on the national stage.

Congressman Sessions Introduces The Safe Cosmetics Modernization Act

U.S. Congressman Pete Sessions (R-Texas) introduced H.R. 4075, The Safe Cosmetics Modernization Act, Nov. 18.

"This legislation reforms and improves the Food and Drug Administration’s ability to streamline and strengthen consumer safety requirements without strangling small businesses in the cosmetic industry with onerous regulations," said Sessions, who is Chairman of the House Rules Committee.

The Campaign For Safe Cosmetics: For the Federal Personal Care Products Safety Act With "Strengthening" Amendments

The Campaign for Safe Cosmetics—a national coalition that works to make personal-care products safe for consumers, workers and the planet, and is a project of the Breast Cancer Fund—announced June 12 that it applauds the work of Senators Dianne Feinstein (D-California) and Susan Collins (R-Maine), urges the United States Senate's Health, Education, Labor and Pensions Committee to take up the Personal Care Products Safety Act and wants it to incorporate "key strengthening amendments to make it a truly ro

Editor's Note: Beauty Industry-FDA Negotiations Stall

Editor's Note: Beauty Industry-FDA Negotiations Stall

Progress toward new federal legislation for beauty products in 2014 took one giant step backward, perhaps more, when the U.S. Food & Drug Administration issued a letter March 6 criticizing industry trade associations and their ongoing efforts to create it--and made that letter public.

“FDA Deputy Commissioner Michael R. Taylor expressed his ‘profound disappointment’ in industry proposals that he contends ‘would actually reduce FDA’s current ability to take action against dangerous cosmetics,’” reported The Wall Street Journal.